15 studies found for:    immune tolerance niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
Conditions: Liver Transplant;   Liver Transplantation
Intervention: Procedure: Immunosuppression withdrawal
2 Recruiting BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Condition: Kidney Transplantation
Interventions: Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
3 Recruiting Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy
Conditions: Cat Allergy;   Cat Hypersensitivity
Interventions: Biological: AMG 157;   Biological: Cat Immunotherapy;   Biological: Cat Immunotherapy Placebo;   Biological: AMG 157 Placebo
4 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
5 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
6 Recruiting Type 1 Diabetes Extension Study
Conditions: Type 1 Diabetes;   Diabetes Mellitus
Intervention:
7 Recruiting A Cohort Study of Operationally Tolerant Allograft Recipients
Conditions: Kidney Transplant;   Liver Transplant
Intervention: Procedure: Blood Draw
8 Recruiting Magnesium Supplementation in People With XMEN Syndrome
Conditions: X-linked Immunodeficiency With Magnesium Defect;   Epstein-Barr Virus (EBV) Infection and Neoplasia
Interventions: Drug: Magnesium L-threonate;   Drug: Placebo;   Drug: Magnesium Sulfate (MgSO)
9 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
10 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
11 Recruiting Molecular Basis of Food Allergy
Conditions: Food Allergy;   Eosinophilic Esophagitis
Intervention:
12 Recruiting Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
Conditions: Liver Disease;   Steatohepatitis;   HIV
Intervention:
13 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
14 Recruiting Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Condition: Neurocysticercosis
Interventions: Other: Placebo;   Drug: Oxfendazole
15 Recruiting Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Conditions: Asthma;   Allergies
Interventions: Biological: Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage;   Procedure: Phlebotomy

Indicates status has not been verified in more than two years